-
Mashup Score: 1Home - 8 month(s) ago
In this live, interactive program, expert faculty will present and discuss the most recent data and clinical advances as well as provide expert perspectives on optimal clinical decision-making for three rare, complex hematologic disorders marked by dysfunction of the complement cascade: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). Clinical case vignettes will be highlighted
Source: na.eventscloud.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Making MRD Assessment Work for AML | ASH Clinical News | American Society of Hematology - 8 month(s) ago
Leah Lawrence is a freelance health writer and editor based in Delaware. Assessment of measurable residual disease (MRD) is more challenging and difficult to perform in acute myeloid leukemia (AML) than in chronic myeloid leukemia (CML) or acute lymphoblastic leukemia (ALL). The concept of MRD is the evolution of how clinicians try to measure and understand responses to therapy, explained Christopher Hourigan, DM, DPhil, a senior investigator at the National Heart, Lung, and Blood Institute of the
Source: ashpublications.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#MRD has become an essential prognostic tool for certain #hematologic #malignancies, but its use in #AML still lags behind. However, recent advances in technology and research are bringing the goal of widespread assessment of MRD in AML closer: https://t.co/oy3lxdachS
-
-
Mashup Score: 0Home - 8 month(s) ago
In this live, interactive program, expert faculty will present and discuss the most recent data and clinical advances as well as provide expert perspectives on optimal clinical decision-making for three rare, complex hematologic disorders marked by dysfunction of the complement cascade: atypical hemolytic uremic syndrome (aHUS), paroxysmal nocturnal hemoglobinuria (PNH), and hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA). Clinical case vignettes will be highlighted
Source: na.eventscloud.comCategories: Dermatology, Latest HeadlinesTweet-
READY FOR #ASH2023 ❓ Join our experts 📆 December 8 at ⏰ 3:30 PM PT. Learn how to accurately diagnose patients with specific #hematologic disorders. Limited seats available, click here now to register: https://t.co/KzIZmM0RBm #OncTwitter #Oncology #aHUS #PNH #HSCTTMA https://t.co/I7p3C7FLSr
-
-
Mashup Score: 4HOME - 7th Annual Live Medical Crossfire®: Hematologic Malignancies - 9 month(s) ago
7th Annual Live Medical Crossfire®: Hematologic Malignancies.
Source: event.gotoper.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Today, #hematologic cancer experts gathered in NYC for the 7th Annual Live Medical Crossfire®: Hematologic Malignancies! Thank you to all our co-chairs, faculty speakers, and attendees who participated! https://t.co/An8mrG6N1t #gotoPER #MXH23 @szusmani @bpromd @Dr_AmerZeidan https://t.co/q2mCi2CWPJ
-
-
Mashup Score: 0COVID-19 Bivalent Boosters Associated With Few Definitive Hematologic AEs | ASH Clinical News | American Society of Hematology - 10 month(s) ago
Skip Nav Destination May 9, 2023 Brandon May is a medical journalist based in Detroit. A cross-sectional study of U.S. safety data found few hematologic adverse events (AEs) after administration of the authorized COVID-19 bivalent…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
A study of U.S. safety data found few #hematologic adverse events (AEs) following administration of the #COVID19 bivalent booster vaccines from #Pfizer and #Moderna, as most AEs could not be definitively attributed to vaccination https://t.co/tmFmiftiRe
-
-
Mashup Score: 1
Researchers are working to optimize the outcomes associated with CAR T-cell therapy, focusing on unique combinations that may enhance T-cell fitness, improving tumor eradication and treatment outcomes.
Source: Targeted OncologyCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
CAR T-cell therapy has revolutionized treatment in the hematologic malignancy space, but it has a long way to go to effectively treat the many #hematologic cancers. #hematology | @harvardmed https://t.co/gqZ4u8KPne https://t.co/gjVzxfxEKh
-
-
Mashup Score: 0
Perlmutter Cancer Center at NYU Langone Lake Success Hematology Oncology provides services for people with cancer and blood disorders. Learn more.
Source: nyulangone.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
This week I will begin seeing patients once weekly at @nyulangone Lake Success Oncology, expanding services for #hematologic malignancies within the @Perlmutter_CC network. https://t.co/xjoBHkAueG
-
-
Mashup Score: 1Adaptive Coping Aids Caregivers of Hematopoietic Cell Transplant Recipients | ASH Clinical News | American Society of Hematology - 1 year(s) ago
Skip Nav Destination December 11, 2022 Caregivers of patients with hematologic malignancies who undergo hematopoietic cell transplantation (HCT) may benefit from resources that facilitate adaptive coping with the demands of…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
Research finds that caregivers of patients with #hematologic #malignancies who undergo #HCT may benefit from resources that facilitate #adaptive #coping, as these individuals face high caregiver burden, psychological distress, and worse quality of life https://t.co/M7YlELmHaC
-
-
Mashup Score: 0The association between nutritional risk index and ICU outcomes across hematologic malignancy patients with acute respiratory failure - PubMed - 1 year(s) ago
Patients with hematological malignancies (HM) are at risk of acute respiratory failure (ARF). Malnutrition, a common association with HM, has the potential to influence ICU outcomes. Geriatric nutritional risk index (G-NRI) is a score derived from albumin and weight, which reflects risk of protein-e …
Source: PubMedCategories: Latest Headlines, PulmonologyTweet-
The association between #nutritional #risk #index and #ICU outcomes across #hematologic #malignancy patients with #acute #respiratory #failure https://t.co/F6RGcxzHaO https://t.co/pYReCH3e84
-
-
Mashup Score: 0
October 2022 | ASH Clinical News | American Society of Hematology October 2022 Hematology Post-Roe The strong link between hematology and maternal health care makes the recent SCOTUS decision particularly poignant for hematologists and their patients. Viewpoints Editor’s Corner Nightlight for Our Souls Education You Make the Call You Make the Call: What would you recommend…
Source: ashpublications.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
The October issue is out now! Click below to check out our feature story on the overturn of #RoeVWade and its impact on #hematologic care, a discussion on treatment of #EssentialThrombocythemia, and coverage of the latest clinical news and studies https://t.co/rKKCmUS9ec https://t.co/IrzmJ3Qnj0
-
READY FOR #ASH2023 ❓ Join our experts 📆 December 8 at ⏰ 3:30 PM PT. Learn how to accurately diagnose patients with specific #hematologic disorders. Limited seats available, click here now to register: https://t.co/YdxmSPuJQk #OncTwitter #Oncology #aHUS #PNH #HSCTTMA https://t.co/j4EYQRwg5y